Immunoglobulin G1 [de-236-glycine,de-C-terminal lysine], anti-(human CD40 antigen) (human monoclonal LVGN7409 ?1-chain), disulfide with human monoclonal LVGN7409 ?-chain, dimer
Metastatic Soft Tissue Sarcoma
M.D. Anderson Cancer Centermonoclonal_antibodyPhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 28/ 100
- Competitive Position
- 95/ 100
Competitive context
103 Active assets in the Metastatic Soft Tissue Sarcoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Palbociclib Brown University | Phase 2 | BB |
FILGRASTIM University of California, Irvine | Phase 3 | BB |
Inno-206 GI Innovation, Inc. | Phase 3 | BB |
Eloxatin OHSU Knight Cancer Institute | Phase 2 | BB |
Cyclophosphamide St. Jude Children's Research Hospital | Phase 2 | BB |
View all 50 →
Same molecule, other indications
Immunoglobulin G1 [de-236-glycine,de-C-terminal lysine], anti-(human CD40 antigen) (human monoclonal LVGN7409 ?1-chain), disulfide with human monoclonal LVGN7409 ?-chain, dimer is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →